Navigation Links
The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
Date:1/11/2010

PARIS and MARSEILLE, France, January 11 /PRNewswire-FirstCall/ -- The INSTITUT CURIE and IPSOGEN (FR0010626028 - ALIPS) announce the signing of a scientific collaboration agreement in the breast cancer domain. Within the framework of this project, the current scientific knowledge on Ipsogen's MapQuant Dx Grade Genomic, HER2 and HR tests will be increased thanks to new data established from a large population of patients treated at the Institut Curie. The aim of this collaboration is to evaluate these tests compared to current breast cancer characterization techniques. Indeed, these new tests could represent, for oncologists and pathologists, helpful decision-making tools enabling them to improve the diagnostic process and optimally adapt their therapeutic strategy to each patient.

Within the framework of this collaboration, the genomic analysis of 200 breast tumors will be performed on the Institut Curie's molecular diagnostic platform, using the expertise of the Institut Curie, in particular the translational research department and clinical teams specialized in breast cancer, and Ipsogen.

Sergio Roman-Roman, Head of Translational Research at the Institut Curie, states: "the existence, at the Institut Curie, of a bank of well-characterized human tumor samples, as well as a particularly strong genomic analysis platform, makes it possible to conduct a reliable assessment of molecular diagnostic tools such as the one that is the subject of this collaboration. The stakes are high because these tools, once validated via research such as those we are beginning today, can be a substantial aid to making therapeutic decisions for women with breast cancer."

Vincent Fert, CEO of Ipsogen, adds: "This first collaboration with the Institut Curie is very important for our company, and reflects the recognition of the quality of our development work. By pooling the complementary scientific and clinical know-how of the Institut Curie and the technical and industrial know-how of Ipsogen, it will be possible to make faster progress towards personalized medicine. It will also enable us, as we have already successfully done in onco-hematology, to continue collaborating with oncologists to develop products that meet their clinical needs in breast cancer."

About the Institut Curie

The Institut Curie is a private non-profit foundation that combines France's largest oncology research center and a state-of-the-art hospital that has pioneered many treatments. It is a reference center in breast cancer, tumors in children and adolescents and eye cancers, and disseminates medical innovations nationwide and worldwide.

Founded in 1909 on a model designed by Marie Curie and still cutting-edge, "from basic research to innovative healthcare," the Institut Curie has some 2,000 researchers, physicians and healthcare staff who all work towards a common goal: to defeat cancer.

A vital link between clinicians and scientists, the Institut Curie's translational research department forms a bridge from research progress to hospitals and industry. This department's competence in genomics, post-genomics, immunomonitoring, pharmacology and biology complement the Institut Curie's scientific and clinical activity.

About IPSOGEN

IPSOGEN, Cancer Profiler, develops and markets molecular diagnostic tests that help map diseases to guide oncologists and patients in their therapeutic decisions.

Strengthened by its scientific and clinical partnerships with recognized academic centers, and its multidisciplinary teams in France and the USA, and with more than 70 tests already used routinely worldwide for the diagnosis, prognosis and follow-up of thousands of patients with leukemia, Ipsogen is now targeting breast cancer with the aim of providing currently inaccessible diagnostic information.

Ipsogen employed 60 people as of June 30, 2009. Its headquarters are located in Marseille, France, with a subsidiary, Ipsogen Inc., in Stamford, CT, USA.

For more information, visit http://www.ipsogen.com

SOURCE Ipsogen SA


'/>"/>
SOURCE Ipsogen SA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Better Hearing Institute Publishes First Comprehensive Guide to Financial Assistance for Hearing Aids
2. Institute of Medicine recommends stricter resident duty hour regulations to prevent medical errors
3. The Black AIDS Institute Kicks Off Its National Platform to Build Black AIDS Awareness
4. The Black AIDS Institute Kicks Off Its National Platform to Build Black AIDS Awareness in Atlanta, GA
5. Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective
6. Mimotopes Awarded a Major Peptide Library Supply Agreement by La Jolla Institute for their Studies Screening Dengue and Tuberculosis Pathogens
7. Aging Institute Reveals 2010 Trends
8. Laser Spine Institute (LSI) Supports Jingle Bell Run
9. NIH awards La Jolla Institute $18.8 million for major infectious disease study
10. San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price
11. Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers ... study of ActiGraph’s CentrePoint Data Hub in a sample of participants ... clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. The ...
(Date:4/28/2017)... York (PRWEB) , ... April 28, 2017 , ... ... anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, ... the hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s ... is the premier online modeling resource for fluorescence microscopists and optical system designers, ... during last 5 years spanning the globe, SearchLight has become a tremendously popular ...
(Date:4/27/2017)... ... April 27, 2017 , ... The Incentive Research Foundation ... A Nudge Guide," a groundbreaking analysis of how behavioral economics can be applied ... immediately to IRR programs, the report highlights proven behavioral economics approaches and the ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain ... Public Leadership in Neurology Award (PLINA). The couple joins a prestigious list of ... President Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... Ind. , April 20, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Care Conference at the InterContinental Hotel in ... Zimmer Biomet will present at 11:20 a.m. Eastern Time. ... be accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
Breaking Medicine Technology: